Comparison 1 Magnesium sulphate versus none/placebo (subgroups by severity of pre‐eclampsia), Outcome 30 Apgar score
1.31. Analysis
Comparison 1 Magnesium sulphate versus…
1.31. Analysis
Comparison 1 Magnesium sulphate versus none/placebo (subgroups by severity of pre‐eclampsia), Outcome 31…
1.31. Analysis Comparison 1 Magnesium sulphate versus none/placebo (subgroups by severity of pre‐eclampsia), Outcome 31 Intubated at place of birth.
1.32. Analysis
Comparison 1 Magnesium sulphate versus…
1.32. Analysis
Comparison 1 Magnesium sulphate versus none/placebo (subgroups by severity of pre‐eclampsia), Outcome 32…
1.32. Analysis Comparison 1 Magnesium sulphate versus none/placebo (subgroups by severity of pre‐eclampsia), Outcome 32 Admission to special care baby unit.
1.33. Analysis
Comparison 1 Magnesium sulphate versus…
1.33. Analysis
Comparison 1 Magnesium sulphate versus none/placebo (subgroups by severity of pre‐eclampsia), Outcome 33…
1.33. Analysis Comparison 1 Magnesium sulphate versus none/placebo (subgroups by severity of pre‐eclampsia), Outcome 33 Blood transfusion.
1.34. Analysis
Comparison 1 Magnesium sulphate versus…
1.34. Analysis
Comparison 1 Magnesium sulphate versus none/placebo (subgroups by severity of pre‐eclampsia), Outcome 34…
1.34. Analysis Comparison 1 Magnesium sulphate versus none/placebo (subgroups by severity of pre‐eclampsia), Outcome 34 Outcome for the children at 18 months (corrected for gestation at birth).
2.1. Analysis
Comparison 2 Magnesium sulphate versus…
2.1. Analysis
Comparison 2 Magnesium sulphate versus none/placebo (subgroups by whether delivered at trial entry),…
2.1. Analysis Comparison 2 Magnesium sulphate versus none/placebo (subgroups by whether delivered at trial entry), Outcome 1 Maternal death.
2.2. Analysis
Comparison 2 Magnesium sulphate versus…
2.2. Analysis
Comparison 2 Magnesium sulphate versus none/placebo (subgroups by whether delivered at trial entry),…
2.2. Analysis Comparison 2 Magnesium sulphate versus none/placebo (subgroups by whether delivered at trial entry), Outcome 2 Eclampsia.
2.3. Analysis
Comparison 2 Magnesium sulphate versus…
2.3. Analysis
Comparison 2 Magnesium sulphate versus none/placebo (subgroups by whether delivered at trial entry),…
2.3. Analysis Comparison 2 Magnesium sulphate versus none/placebo (subgroups by whether delivered at trial entry), Outcome 3 Serious maternal morbidity.
3.1. Analysis
Comparison 3 Magnesium sulphate versus…
3.1. Analysis
Comparison 3 Magnesium sulphate versus none/placebo (subgroups by gestation at trial entry), Outcome…
3.1. Analysis Comparison 3 Magnesium sulphate versus none/placebo (subgroups by gestation at trial entry), Outcome 1 Maternal death.
3.2. Analysis
Comparison 3 Magnesium sulphate versus…
3.2. Analysis
Comparison 3 Magnesium sulphate versus none/placebo (subgroups by gestation at trial entry), Outcome…
3.2. Analysis Comparison 3 Magnesium sulphate versus none/placebo (subgroups by gestation at trial entry), Outcome 2 Eclampsia.
3.3. Analysis
Comparison 3 Magnesium sulphate versus…
3.3. Analysis
Comparison 3 Magnesium sulphate versus none/placebo (subgroups by gestation at trial entry), Outcome…
3.3. Analysis Comparison 3 Magnesium sulphate versus none/placebo (subgroups by gestation at trial entry), Outcome 3 Serious maternal morbidity.
3.4. Analysis
Comparison 3 Magnesium sulphate versus…
3.4. Analysis
Comparison 3 Magnesium sulphate versus none/placebo (subgroups by gestation at trial entry), Outcome…
3.4. Analysis Comparison 3 Magnesium sulphate versus none/placebo (subgroups by gestation at trial entry), Outcome 4 Stillbirths and neonatal deaths.
3.5. Analysis
Comparison 3 Magnesium sulphate versus…
3.5. Analysis
Comparison 3 Magnesium sulphate versus none/placebo (subgroups by gestation at trial entry), Outcome…
3.5. Analysis Comparison 3 Magnesium sulphate versus none/placebo (subgroups by gestation at trial entry), Outcome 5 Death or in special care baby unit > 7 days.
4.1. Analysis
Comparison 4 Magnesium sulphate versus…
4.1. Analysis
Comparison 4 Magnesium sulphate versus none/placebo (subgroups by whether anticonvulsant before trial entry),…
4.1. Analysis Comparison 4 Magnesium sulphate versus none/placebo (subgroups by whether anticonvulsant before trial entry), Outcome 1 Maternal death.
4.2. Analysis
Comparison 4 Magnesium sulphate versus…
4.2. Analysis
Comparison 4 Magnesium sulphate versus none/placebo (subgroups by whether anticonvulsant before trial entry),…
4.2. Analysis Comparison 4 Magnesium sulphate versus none/placebo (subgroups by whether anticonvulsant before trial entry), Outcome 2 Eclampsia.
4.3. Analysis
Comparison 4 Magnesium sulphate versus…
4.3. Analysis
Comparison 4 Magnesium sulphate versus none/placebo (subgroups by whether anticonvulsant before trial entry),…
4.3. Analysis Comparison 4 Magnesium sulphate versus none/placebo (subgroups by whether anticonvulsant before trial entry), Outcome 3 Serious maternal morbidity.
4.4. Analysis
Comparison 4 Magnesium sulphate versus…
4.4. Analysis
Comparison 4 Magnesium sulphate versus none/placebo (subgroups by whether anticonvulsant before trial entry),…
4.4. Analysis Comparison 4 Magnesium sulphate versus none/placebo (subgroups by whether anticonvulsant before trial entry), Outcome 4 Stillbirths and neonatal deaths.
4.5. Analysis
Comparison 4 Magnesium sulphate versus…
4.5. Analysis
Comparison 4 Magnesium sulphate versus none/placebo (subgroups by whether anticonvulsant before trial entry),…
4.5. Analysis Comparison 4 Magnesium sulphate versus none/placebo (subgroups by whether anticonvulsant before trial entry), Outcome 5 Death or in special care baby unit > 7 days.
5.1. Analysis
Comparison 5 Magnesium sulphate versus…
5.1. Analysis
Comparison 5 Magnesium sulphate versus none/placebo (subgroups by dose and route of administration…
5.1. Analysis Comparison 5 Magnesium sulphate versus none/placebo (subgroups by dose and route of administration for maintenance therapy), Outcome 1 Maternal death.
5.2. Analysis
Comparison 5 Magnesium sulphate versus…
5.2. Analysis
Comparison 5 Magnesium sulphate versus none/placebo (subgroups by dose and route of administration…
5.2. Analysis Comparison 5 Magnesium sulphate versus none/placebo (subgroups by dose and route of administration for maintenance therapy), Outcome 2 Eclampsia.
5.3. Analysis
Comparison 5 Magnesium sulphate versus…
5.3. Analysis
Comparison 5 Magnesium sulphate versus none/placebo (subgroups by dose and route of administration…
5.3. Analysis Comparison 5 Magnesium sulphate versus none/placebo (subgroups by dose and route of administration for maintenance therapy), Outcome 3 Stillbirths and neonatal deaths.
5.4. Analysis
Comparison 5 Magnesium sulphate versus…
5.4. Analysis
Comparison 5 Magnesium sulphate versus none/placebo (subgroups by dose and route of administration…
5.4. Analysis Comparison 5 Magnesium sulphate versus none/placebo (subgroups by dose and route of administration for maintenance therapy), Outcome 4 Any reported side effects.
6.1. Analysis
Comparison 6 Magnesium sulphate versus…
6.1. Analysis
Comparison 6 Magnesium sulphate versus phenytoin, Outcome 1 Eclampsia.
6.1. Analysis Comparison 6 Magnesium sulphate versus phenytoin, Outcome 1 Eclampsia.
6.2. Analysis
Comparison 6 Magnesium sulphate versus…
6.2. Analysis
Comparison 6 Magnesium sulphate versus phenytoin, Outcome 2 Complications of labour.
6.2. Analysis Comparison 6 Magnesium sulphate versus phenytoin, Outcome 2 Complications of labour.
6.3. Analysis
Comparison 6 Magnesium sulphate versus…
6.3. Analysis
Comparison 6 Magnesium sulphate versus phenytoin, Outcome 3 Caesarean section.
6.3. Analysis Comparison 6 Magnesium sulphate versus phenytoin, Outcome 3 Caesarean section.
6.4. Analysis
Comparison 6 Magnesium sulphate versus…
6.4. Analysis
Comparison 6 Magnesium sulphate versus phenytoin, Outcome 4 Mortality for the fetus or…
6.4. Analysis Comparison 6 Magnesium sulphate versus phenytoin, Outcome 4 Mortality for the fetus or infant (by time of death).
6.5. Analysis
Comparison 6 Magnesium sulphate versus…
6.5. Analysis
Comparison 6 Magnesium sulphate versus phenytoin, Outcome 5 Infant morbidity.
6.5. Analysis Comparison 6 Magnesium sulphate versus phenytoin, Outcome 5 Infant morbidity.
7.1. Analysis
Comparison 7 Magnesium sulphate versus…
7.1. Analysis
Comparison 7 Magnesium sulphate versus diazepam, Outcome 1 Eclampsia.
7.1. Analysis Comparison 7 Magnesium sulphate versus diazepam, Outcome 1 Eclampsia.
7.2. Analysis
Comparison 7 Magnesium sulphate versus…
7.2. Analysis
Comparison 7 Magnesium sulphate versus diazepam, Outcome 2 Caesarean section.
7.2. Analysis Comparison 7 Magnesium sulphate versus diazepam, Outcome 2 Caesarean section.
7.3. Analysis
Comparison 7 Magnesium sulphate versus…
7.3. Analysis
Comparison 7 Magnesium sulphate versus diazepam, Outcome 3 Stillbirths and neonatal deaths.
7.3. Analysis Comparison 7 Magnesium sulphate versus diazepam, Outcome 3 Stillbirths and neonatal deaths.
8.1. Analysis
Comparison 8 Magnesium sulphate versus…
8.1. Analysis
Comparison 8 Magnesium sulphate versus nimodipine, Outcome 1 Eclampsia.
8.1. Analysis Comparison 8 Magnesium sulphate versus nimodipine, Outcome 1 Eclampsia.
8.2. Analysis
Comparison 8 Magnesium sulphate versus…
8.2. Analysis
Comparison 8 Magnesium sulphate versus nimodipine, Outcome 2 Stroke.
8.2. Analysis Comparison 8 Magnesium sulphate versus nimodipine, Outcome 2 Stroke.
8.3. Analysis
Comparison 8 Magnesium sulphate versus…
8.3. Analysis
Comparison 8 Magnesium sulphate versus nimodipine, Outcome 3 Coagulopathy.
8.3. Analysis Comparison 8 Magnesium sulphate versus nimodipine, Outcome 3 Coagulopathy.
8.4. Analysis
Comparison 8 Magnesium sulphate versus…
8.4. Analysis
Comparison 8 Magnesium sulphate versus nimodipine, Outcome 4 Respiratory problems.
8.4. Analysis Comparison 8 Magnesium sulphate versus nimodipine, Outcome 4 Respiratory problems.
8.5. Analysis
Comparison 8 Magnesium sulphate versus…
8.5. Analysis
Comparison 8 Magnesium sulphate versus nimodipine, Outcome 5 Cardiac failure.
8.5. Analysis Comparison 8 Magnesium sulphate versus nimodipine, Outcome 5 Cardiac failure.
8.6. Analysis
Comparison 8 Magnesium sulphate versus…
8.6. Analysis
Comparison 8 Magnesium sulphate versus nimodipine, Outcome 6 Respiratory depression.
8.6. Analysis Comparison 8 Magnesium sulphate versus nimodipine, Outcome 6 Respiratory depression.
8.7. Analysis
Comparison 8 Magnesium sulphate versus…
8.7. Analysis
Comparison 8 Magnesium sulphate versus nimodipine, Outcome 7 Antihypertensive drug.
8.7. Analysis Comparison 8 Magnesium sulphate versus nimodipine, Outcome 7 Antihypertensive drug.
8.8. Analysis
Comparison 8 Magnesium sulphate versus…
8.8. Analysis
Comparison 8 Magnesium sulphate versus nimodipine, Outcome 8 Oliguria.
8.8. Analysis Comparison 8 Magnesium sulphate versus nimodipine, Outcome 8 Oliguria.
8.9. Analysis
Comparison 8 Magnesium sulphate versus…
8.9. Analysis
Comparison 8 Magnesium sulphate versus nimodipine, Outcome 9 Side effects.
8.9. Analysis Comparison 8 Magnesium sulphate versus nimodipine, Outcome 9 Side effects.
8.10. Analysis
Comparison 8 Magnesium sulphate versus…
8.10. Analysis
Comparison 8 Magnesium sulphate versus nimodipine, Outcome 10 Placental abruption.
8.10. Analysis Comparison 8 Magnesium sulphate versus nimodipine, Outcome 10 Placental abruption.
8.11. Analysis
Comparison 8 Magnesium sulphate versus…
8.11. Analysis
Comparison 8 Magnesium sulphate versus nimodipine, Outcome 11 Caesarean section.
8.11. Analysis Comparison 8 Magnesium sulphate versus nimodipine, Outcome 11 Caesarean section.
8.12. Analysis
Comparison 8 Magnesium sulphate versus…
8.12. Analysis
Comparison 8 Magnesium sulphate versus nimodipine, Outcome 12 Postpartum haemorrhage.
8.12. Analysis Comparison 8 Magnesium sulphate versus nimodipine, Outcome 12 Postpartum haemorrhage.
8.13. Analysis
Comparison 8 Magnesium sulphate versus…
8.13. Analysis
Comparison 8 Magnesium sulphate versus nimodipine, Outcome 13 Respiratory distress syndrome.
8.13. Analysis Comparison 8 Magnesium sulphate versus nimodipine, Outcome 13 Respiratory distress syndrome.
8.14. Analysis
Comparison 8 Magnesium sulphate versus…
8.14. Analysis
Comparison 8 Magnesium sulphate versus nimodipine, Outcome 14 Neonatal hypotonia.
8.14. Analysis Comparison 8 Magnesium sulphate versus nimodipine, Outcome 14 Neonatal hypotonia.
8.15. Analysis
Comparison 8 Magnesium sulphate versus…
8.15. Analysis
Comparison 8 Magnesium sulphate versus nimodipine, Outcome 15 Baby intubated.
8.15. Analysis Comparison 8 Magnesium sulphate versus nimodipine, Outcome 15 Baby intubated.
8.16. Analysis
Comparison 8 Magnesium sulphate versus…
8.16. Analysis
Comparison 8 Magnesium sulphate versus nimodipine, Outcome 16 Neonatal hypotension.
8.16. Analysis Comparison 8 Magnesium sulphate versus nimodipine, Outcome 16 Neonatal hypotension.
9.1. Analysis
Comparison 9 Magnesium chloride versus…
9.1. Analysis
Comparison 9 Magnesium chloride versus methyl dopa, Outcome 1 Other antihypertensive therapy.
9.1. Analysis Comparison 9 Magnesium chloride versus methyl dopa, Outcome 1 Other antihypertensive therapy.
9.2. Analysis
Comparison 9 Magnesium chloride versus…
9.2. Analysis
Comparison 9 Magnesium chloride versus methyl dopa, Outcome 2 Admission to special care…
9.2. Analysis Comparison 9 Magnesium chloride versus methyl dopa, Outcome 2 Admission to special care baby unit.
10.1. Analysis
Comparison 10 Magnesium sulphate versus…
10.1. Analysis
Comparison 10 Magnesium sulphate versus nitrate, Outcome 1 Eclampsia.
10.1. Analysis Comparison 10 Magnesium sulphate versus nitrate, Outcome 1 Eclampsia.